Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Repeat Dosing of Eltrombopag in Chronic ITP
NCT00424177Phase 2Completed
- Sponsor
- GSK
- Start
- Mar 2007
- Primary completion
- Aug 2008
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of eltrombopag in immune thrombocytopenia (ITP), sponsored by GSK. Started Mar 2007; status: completed.
02
Drugs
eltrombopag
03
Conditions
immune thrombocytopenia (ITP)
Beyond the preview
Go deeper on NCT00424177.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00424177.